Spontaneous Hyphema during Ibrutinib Treatment in a CLL Patient.

Case Rep Hematol

Department of Hematology and Oncology, Trinity Health Oakland, Pontiac, MI, USA.

Published: December 2023

Ibrutinib is an oral, first-line, targeted therapy for chronic lymphocytic leukemia (CLL). Commonly reported adverse events are diarrhea, fatigue, and musculoskeletal pain, but rarely it has been associated with visual disturbances. Here, we present a rare case of spontaneous hyphema in a 60-year-old patient with a known diagnosis of CLL on ibrutinib treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10735723PMC
http://dx.doi.org/10.1155/2023/1691996DOI Listing

Publication Analysis

Top Keywords

spontaneous hyphema
8
ibrutinib treatment
8
hyphema ibrutinib
4
treatment cll
4
cll patient
4
patient ibrutinib
4
ibrutinib oral
4
oral first-line
4
first-line targeted
4
targeted therapy
4

Similar Publications

Long-term Follow Up of a Complex Case of Foldable Capsular Vitreous Bag Implantation.

Retin Cases Brief Rep

December 2024

Liverpool Ocular Oncology Research Centre, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.

Purpose: The Foldable Capsular Vitreous Bag (FCVB) implant is useful in maintaining ocular structure in cases of chronic hypotony secondary to trauma or repeated surgery. There are few published reports of long-term outcomes and no indication of the chronic cellular changes of the adjacent tissues associated with FCVB implantation. We describe one of few FCVB cases in the UK and present histological findings associated with it following secondary enucleation.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the occurrence of hyphema (bleeding in the anterior chamber) after PRESERFLO MicroShunt surgery in glaucoma patients and its connection to the tube insertion position.
  • Out of 66 eyes reviewed, 23 experienced hyphema, equating to a 35% occurrence rate, with bleeding observed during surgery in 8 cases.
  • Despite the high frequency of hyphema, all cases resolved within weeks with stable intraocular pressure and visual acuity, highlighting the need to inform patients about this risk before surgery.
View Article and Find Full Text PDF

Delayed onset Spontaneous Hyphema after OMNI® Surgical System.

J Glaucoma

October 2024

Department of Ophthalmology, Mayo Clinic 200 First St SW, Rochester, MN, 55905.

Minimally invasive glaucoma surgery (MIGS) offers options for glaucoma treatment that have generally improved safety profiles compared with filtering surgery. MIGS vary in design and procedure, but all angle-based MIGS function by bypassing or removing aqueous humor outflow resistance at the level of the trabecular meshwork. This can lower intraocular pressure but also remove the blood-aqueous barrier.

View Article and Find Full Text PDF

Prcis: Gonioscopy-assisted transluminal trabeculotomy yielded a 45% reduction in intraocular pressure in primary congenital glaucoma, with a success rate of 86.6%. Hyphema was the most common complication.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!